Inhalation Sciences: First patient enrolled in clinical trial of PreciseInhale

Report this content

(Stockholm, Sweden, June 16, 2021) The first patient has been enrolled, on schedule, in ISAB’s clinical trial of its aerosol generating system PreciseInhale®. CEO Manoush Masarrat: “Clinical validation of PreciseInhale® would be transformational for ISAB, opening up new markets and new opportunities for major growth.”

On Wednesday 16 June, the first 4 healthy volunteer patients enrolled on the landmark clinical trial of PreciseInhale®. In total 12 patients will take part. The study aims to be finalized before the end of 2021. The study is being run by Clinical Trial Consultants AB (CTC), an award-winning CRO and clinical trial consultancy with extensive test facilities adjacent to Uppsala University Hospital.

Successful clinical validation would make PreciseInhale® the first aerosol generation platform that could be used from the drug discovery phase, through preclinical studies, all the way to phase I clinical trials in humans. This could significantly reduce translational errors between research stages, reducing risk, costs and accelerating drug development.

ISAB CEO Manoush Masarrat: “The clinical validation of PreciseInhale® will potentially open up new markets valued in the billions of SEK. It would significantly reduce drug development time for pharmaceutical companies, making PreciseInhale® the leading low-risk aerosol delivery system on the market.”

For more information about Inhalation Sciences, please contact:

Manoush Masarrat, CEO


Mobile: +46 (0)73 628 9153

About Inhalations Sciences Sweden AB (publ)

Inhalation Sciences Sweden AB (publ) develops and commercializes world-leading instruments and services for research into inhalation. The company’s patented lab instruments PreciseInhale® and DissolvIt® enable researchers in the pharma industry to make drug pipeline decisions at an early stage, saving time and resources for R&D departments, and enables researchers in academic institutions to define how aerosols and small particles impact our lungs, and so our health, when being inhaled.